BMJ 2002;325:203-206 ( 27 July )

Clinical review

Human African trypanosomiasis

August Stich, group leader, clinical tropical medicine ^a, Paulo M Abel, national coordinator ^b, Sanjeev Krishna, professor of molecular parasitology and medicine ^c. 

^a Medical Mission Institute, Department of Tropical Medicine and Epidemic Control, D-97074 Würzburg, Germany, ^b Angotrip Project, Caritas Luanda, Angola, ^c Department of Infectious Diseases, St George's Hospital Medical School, London SW17 0RE

Correspondence to: A Stich august.stich@mail.uni-wuerzburg.de

The first 150 words of the full text of this article appear below.

The re-emergence of sleeping sickness presents a major public health problem

Human African trypanosomiasis or sleeping sickness is one of the most important but equally most neglected tropical infections. It is caused by a protozoan, Trypanosoma brucei, which is transmitted to humans through the bite of a tsetse fly (Glossina spp).¹ Patchy distribution of the various vector species confines the disease to some 200 microfoci in sub-Saharan Africa (fig 1). The disease had been successfully controlled by a combination of approaches, including treatment of patients, active case finding, and measures to deal with the vector.² Since the 1970s, however, the disease has re-emerged as a new epidemic of immense proportions, which, until recently, received little attention from the international community (fig 2). According to the World Health Organization, about 500 000 people already carry trypanosomes and will die if left untreated.³

Table Removed (Available Only in the Full Text)

Table Removed (Available Only in the Full Text)

	Sources and methods

Extensive literature exists on human African trypanosomiasis . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

African sleeping sickness

Francesco Checchi and Michael P Barrett
BMJ 2008 336: 679-680. [Extract] [Full Text] [PDF]

Diagnosing human African trypanosomiasis in Angola using a card agglutination test: observational study of active and passive case finding strategies

Walter O Inojosa, Inacio Augusto, Zeno Bisoffi, Teofile Josenado, Paulo M Abel, August Stich, and Christopher J M Whitty
BMJ 2006 332: 1479. [Abstract] [Full Text] [PDF]

Sleeping sickness is re-emerging
BMJ 2002 325: 0. [Full Text]

This article has been cited by other articles:

• Wang, Y., Utzinger, J., Saric, J., Li, J. V., Burckhardt, J., Dirnhofer, S., Nicholson, J. K., Singer, B. H., Brun, R., Holmes, E. (2008). Global metabolic responses of mice to Trypanosoma brucei brucei infection. Proc. Natl. Acad. Sci. USA 105: 6127-6132 [Abstract] [Full text]  
• Checchi, F., Barrett, M. P (2008). African sleeping sickness. BMJ 336: 679-680 [Full text]  
• Hans, J., Hajduk, S. L., Madison-Antenucci, S. (2007). RNA-editing-associated protein 1 null mutant reveals link to mitochondrial RNA stability. RNA 13: 881-889 [Abstract] [Full text]  
• Mishina, Y. V., Krishna, S., Haynes, R. K., Meade, J. C. (2007). Artemisinins Inhibit Trypanosoma cruzi and Trypanosoma brucei rhodesiense In Vitro Growth. Antimicrob. Agents Chemother. 51: 1852-1854 [Abstract] [Full text]  
• Inojosa, W. O, Augusto, I., Bisoffi, Z., Josenado, T., Abel, P. M, Stich, A., Whitty, C. J M (2006). Diagnosing human African trypanosomiasis in Angola using a card agglutination test: observational study of active and passive case finding strategies. BMJ 332: 1479- [Abstract] [Full text]  
• Kulikowicz, T., Shapiro, T. A. (2006). Distinct Genes Encode Type II Topoisomerases for the Nucleus and Mitochondrion in the Protozoan Parasite Trypanosoma brucei. J. Biol. Chem. 281: 3048-3056 [Abstract] [Full text]  

Online poll

Find out more here>> and here>>